Urothelial Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00958Carboplatin1Recruiting1
DB00515Cisplatin1Recruiting1
DB13007Enfortumab vedotin1Recruiting1
DB00441Gemcitabine1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB00041Aldesleukin1 / 2Recruiting1
DB00041Aldesleukin1 / 2Terminated1
DB00531Cyclophosphamide1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Terminated1
DB11714Durvalumab1 / 2Active Not Recruiting1
DB11714Durvalumab1 / 2Recruiting1
DB01073Fludarabine1 / 2Recruiting1
DB01073Fludarabine1 / 2Terminated1
DB09037Pembrolizumab1 / 2Withdrawn1
DB11945Avelumab2Recruiting1
DB06626Axitinib2Recruiting1
DB00515Cisplatin2Completed1
DB01234Dexamethasone2Recruiting1
DB11714Durvalumab2Recruiting1
DB13007Enfortumab vedotin2Recruiting1
DB12147Erdafitinib2Enrolling by Invitation1
DB01590Everolimus2Completed1
DB00441Gemcitabine2Completed1
DB00441Gemcitabine2Terminated1
DB01259Lapatinib2Withdrawn1
DB01229Paclitaxel2Active Not Recruiting1
DB01229Paclitaxel2Terminated1
DB01229Paclitaxel2Withdrawn1
DB09037Pembrolizumab2Active Not Recruiting2
DB00642Pemetrexed2Recruiting1
DB01268Sunitinib2Completed2
DB11945Avelumab3Recruiting1
DB00958Carboplatin3Recruiting2
DB00515Cisplatin3Recruiting2
DB01248Docetaxel3Active Not Recruiting1
DB01248Docetaxel3Recruiting2
DB11714Durvalumab3Recruiting1
DB13007Enfortumab vedotin3Recruiting1
DB12147Erdafitinib3Recruiting1
DB00441Gemcitabine3Recruiting2
DB06186Ipilimumab3Recruiting1
DB09035Nivolumab3Recruiting1
DB01229Paclitaxel3Active Not Recruiting1
DB01229Paclitaxel3Recruiting1
DB09037Pembrolizumab3Active Not Recruiting1
DB09037Pembrolizumab3Recruiting1
DB11771Tremelimumab3Recruiting1
DB11641Vinflunine3Active Not Recruiting1
DB11641Vinflunine3Recruiting2
DB09037PembrolizumabNot AvailableRecruiting1